Apellis Pharmaceuticals, Inc. has recently announced a significant milestone for their groundbreaking treatment, SYFOVRE® (pegcetacoplan injection), which addresses geographic atrophy ...
BridgeBio Pharma, Inc. (NASDAQ:BBIO) has recently received an average rating of "Moderate Buy" from ten different ratings firms, according to ...
Prelude Capital Management LLC, a leading institutional investor, recently made a significant reduction in its holdings of BridgeBio Pharma, Inc. ...
September 19, 2023 - DnB Asset Management AS, a leading asset management firm, has recently acquired a new position in ...
Harbor Capital Advisors Inc., a financial investment firm, has recently acquired a new stake in Altair Engineering Inc., according to ...
ExodusPoint Capital Management LP, an institutional investor, has revealed its increased stake in The Marcus Co. (NYSE:MCS) during the first ...
Bank of New York Mellon Corp recently increased its stake in BridgeBio Pharma, Inc. by 7.7% during the first quarter, ...
On August 28, 2023, Mizuho analyst Salim Syed expressed his positive stance on BridgeBio Pharma (NASDAQ: BBIO) by reiterating his ...
On August 28, 2023, Eaton Corporation PLC, a renowned power management company, made an exciting announcement regarding their plans to ...
BridgeBio Pharma, Inc. (NASDAQ:BBIO) has received a "Moderate Buy" consensus recommendation from ten ratings firms that cover the stock, according ...